Early trial tests new pill for common chronic pain
NCT ID NCT06810245
Summary
This study tested a new oral medication, PIPE-791, to see if it is safe and can help reduce pain in adults with long-term osteoarthritis pain or chronic low back pain. In this small, early-stage trial, 43 participants took the drug or a placebo for 4-week periods to compare effects. The main goals were to check for side effects and see if the drug lowered daily pain scores.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Altoona Center of Clinical Research
Duncansville, Pennsylvania, 16635, United States
-
Arizona Research Center
Phoenix, Arizona, 85053, United States
-
Drug Studies America
Marietta, Georgia, 30060, United States
-
Drug Trials America
Hartsdale, New York, 10530, United States
-
JBR Clinical Research
Salt Lake City, Utah, 84107, United States
Conditions
Explore the condition pages connected to this study.